Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

UbcH10 DN Citations (2)

Originally described in: Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase.
Townsley FM, Aristarkhov A, Beck S, Hershko A, Ruderman JV Proc Natl Acad Sci U S A 1997 Mar 18;94(6):2362-7. PubMed Journal

Articles Citing UbcH10 DN

Articles
Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation. Bose MV, Gopisetty G, Selvaluxmy G, Rajkumar T. Int J Radiat Biol. 2012 Sep;88(9):629-34. doi: 10.3109/09553002.2012.702299. Epub 2012 Jul 4. PubMed
Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole. Rawat A, Gopal G, Selvaluxmy G, Rajkumar T. Cell Oncol (Dordr). 2013 Dec;36(6):459-67. doi: 10.1007/s13402-013-0150-8. Epub 2013 Sep 27. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.